... been difficult to quantify,” said NIMH Director Thomas R. Insel, M.D. “This study shows us ... 2002 National Comorbidity Survey Replication (NCS-R), a nationally representative study of Americans age 18 ...
... in schizophrenia and autism,” explained NIMH Director Thomas R. Insel, M.D. “Now we have a dramatic demonstration that genetic vulnerabilities for these illnesses may not be inherited from ...
... a different genetic cause," explained NIMH Director Thomas R. Insel, M.D. "The one unifying observation from this new report is that all of the relevant mutations could disrupt the ...
... and the postpartum period. "For the first time, we may have a highly useful model of postpartum depression," said NIMH Director Thomas R. Insel, M.D. "The new research also points to ...
... and unearthed surprising results," said NIMH Director Thomas R. Insel, M.D. "Improved understanding of these abnormalities could lead to new hope for the millions of Americans affected by ...
... have more severe symptoms and a worse prognosis than those who develop the disorder in adulthood," said NIMH Director Thomas R. Insel, M.D. "The newer atypical antipsychotics are ...
... 's success in school, jeopardize his or her relationships with family, and inhibit social functioning," said NIMH Director Thomas R. Insel, M.D. "This study provides strong evidence and ...
...
For the first time, this study has pinpointed what grabs the attention of toddlers with ASDs," said NIMH Director Thomas R. Insel, M.D. "In addition to potential uses in screening ...
... spectrum disorders face an enormous number of treatment options, not all of which are research based," said Thomas R. Insel, MD, Director of the National Institute of Mental Health (NIMH). "Studies ...
... checks and balances necessary for scientific progress," said Thomas R. Insel, M.D., director of NIMH. "We are still in the early days of understanding how genes and environment interact to ...
... fresh look at our diagnostic categories," said Thomas R. Insel, M.D., director of the National ... contribution; now we have more than 30 percent accounted for," said Thomas Lehner, Ph.D., MPH, chief ...
... selectively and potently targets the synaptic defect.
Thomas R. Insel, M.D., director of the National Institute of Mental Health, said, "This project is the culmination of years of fundamental ...
... with some symptoms of autism, but its potential is limited," said NIMH Director Thomas R. Insel. "This study shows promise of a more effective treatment protocol that could improve life for children ...
